Pediatric neurologists and neurosurgeons from Columbia and Weill Cornell Medicine are internationally recognized for their clinical excellence and innovative research, which enables the optimal care for diseases and injuries to the brain or spinal cord. As physician-scientists, they also pursue research with a mission to improve outcomes, discover cures for devastating illnesses, and enhance quality of life.
Pediatric Neurology
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
